Cardiovascular Disease Archives - The Cardiology Advisor

Cardiovascular Disease

Vascepa Approved to Cut Risk for CV Events in High-Risk Patients With Elevated Triglycerides

The Food and Drug Administration (FDA) has approved the use of Vascepa (icosapent ethyl; Amarin Pharma) as an adjunct to maximally tolerated statin therapy to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina requiring hospitalization in adult patients with elevated triglyceride (TG) levels (≥150mg/dL) and established CV disease or diabetes mellitus…

Next post in Clinical Charts